(Q43512318)

24 November 2017

title

Reference intervals for glucose, beta-cell polypeptides, and counterregulatory factors during prolonged fasting (English)

1 reference

24 November 2017

5

1 reference

24 November 2017

Hojlund K

1

1 reference

24 November 2017

Wildner-Christensen M

2

1 reference

24 November 2017

Eshøj O

3

1 reference

24 November 2017

Skjaerbaek C

4

1 reference

24 November 2017

Koldkjaer O

6

1 reference

24 November 2017

Møller Jensen D

7

1 reference

24 November 2017

Beck-Nielsen H

8

1 reference

24 November 2017

publication date

1 January 2001

1 reference

American Journal of Physiology - Endocrinology and Metabolism

24 November 2017

published in

1 reference

24 November 2017

volume

280

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

E50-8

1 reference

Gender differences in counterregulation to hypoglycaemia

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

The effect of a 72-h fast on plasma levels of pituitary, adrenal, thyroid, pancreatic and gastrointestinal hormones in healthy men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Glucose counterregulation: prevention and correction of hypoglycemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Role of growth hormone in glucose counterregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counterregulation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Contribution of adrenergic mechanisms to glucose counterregulation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Contribution of cortisol to glucose counterregulation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Demonstration of a role for growth hormone in glucose counterregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Free insulin-like growth factors in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Effect of changes in plasma levels of free fatty acids on plasma glucagon, insulin, and growth hormone in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Evidence that glicentin contains the entire sequence of glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Decreased epinephrine responses to hypoglycemia during sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Importance of blood glucose concentration in regulating lipolysis during fasting in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Lymphocyte norepinephrine and epinephrine, but not plasma catecholamines predict lymphocyte cAMP production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Homeostasis During Fasting. II. Hormone Substrate Differences Between Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Metabolic effects of growth hormone in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Classification of hypoglycemic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Diagnostic approach to adults with hypoglycemic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

Radioimmunoassay of extracted glucagon compared with three non-extraction assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E50

10.1152/AJPENDO.2001.280.1.E50

21 January 2018

Identifiers

DOI

0 references

1 reference